Derived from human mesenchymal stromal cells, our osteoblast model can be used to test the effect of compounds on cell
In vitro cell biology
Understanding how your compound interacts with cells is crucial for assessing its efficacy and strategically planning preclinical studies—particularly when it comes to selecting the most appropriate animal species and models.
At Atlantic Bone Screen, we combine the expertise of our highly skilled team with a cutting-edge technical platform to support your research at every step. We offer comprehensive in-vitro evaluations of drug candidates, nutraceuticals, biomaterials, and medical devices, focusing on osteogenesis, inflammation, and cytotoxicity.
Our services include:
- High-throughput screening of potential compounds
- In-depth characterization of therapeutic effects
- Detailed analysis of mechanisms of action
Derived from primary human CD14+ cells, our osteoclast model can predict the anti-resorption activity of test compounds
In vitro screening of the effect of your compounds on primary chondrocytes stimulated with IL-1β
Derived from human monocytes, macrophages can be used to highlight anti or pro-inflammatory effect of compounds
From validated human healthy donors, skin explants are used to evaluate dermocosmetics with histology and biomarkers analyses
In vitro biocompatibility evaluation performed on biomaterials according to ISO 10993 part5.
in vitro screening services for anti-cancer drug development using tumor cell lines
in vitro models development or transfer is also done by our Team to answer your specific needs.